Rachael M. Crist, PhD
Scientist II, Alliance Management
Dr. Crist is a Scientist II in NCL’s Alliance Management Division, part of a team of scientists responsible for managing the NCL’s external collaborations with academic and pharmaceutical organizations from around the globe, as well as interfacing with various agencies within the US Government. In this role, Rachael manages multiple interdisciplinary scientific projects, coordinates internal and external data review meetings, provides scientific and technical writing expertise, and aids in the production of a variety of scientific documents, technical reports, and presentations. She also participates in panel reviews, evaluating candidate nanotech drugs and diagnostics with regards to physical and chemical attributes, in vitro biological profiles, and in vivo safety and efficacy profiles, and assists with preclinical data analysis. Her areas of interest include nanotech drug development and the environmental, health and safety issues associated with nanomaterials.
Prior to joining the NCL, Dr. Crist completed a post-doctoral fellowship with the HIV Drug Resistance Program, National Cancer Institute at Frederick, exploring the mechanism and requirements for the retroviral assembly process. She received her Ph.D. degree in chemistry from Michigan State University, studying the underlying protein/substrate interactions modulating color vision, and her B.S. degree in chemistry from Miami University, investigating conformational tendencies of small polyamides for rational drug design. Her research experiences include protein chemistry, molecular biology, virology, organic synthesis, and computational chemistry.